CRPC w/ Bone Metastases - Results from #100

68Ga-PSMA PET/CT Imaging and 153Sm-EDTMP Bone Pain Palliation Therapy April 10, 2016

Healing Sacral Fracture Masquerading as Metastatic Bone Disease on a 68Ga-PSMA PET/CT April 10, 2016

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer April 6, 2016

JOURNAL CLUB: Identification of Bone Metastasis With Routine Prostate MRI: A Study of Patients With Newly Diagnosed Prostate Cancer April 6, 2016

Chemotherapy following radium-223 dichloride treatment in ALSYMPCA March 29, 2016

Patient-reported quality of life analysis of radium-223 dichloride from the phase 3 ALSYMPCA study February 29, 2016

The Clinical and Economic Impacts of Skeletal-Related Events Among Medicare Enrollees With Prostate Cancer Metastatic to Bone February 25, 2016

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 February 25, 2016

Health resource utilisation associated with skeletal-related events in patients with bone metastases secondary to solid tumours: regional comparisons in an observational study February 24, 2016

Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer February 22, 2016

A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer February 22, 2016

Lutetium-177 PSMA Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy February 22, 2016

Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial February 22, 2016

Skeletal Tumor Burden on Baseline 18F-Fluoride PET/CT Predicts Bone Marrow Failure After 223Ra Therapy February 21, 2016

Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer February 20, 2016

Radiotherapy Combined With Androgen Deprivation for Bone Oligometastases After Primary Curative Radiotherapy for Prostate Cancer: A Retrospective Study February 15, 2016

Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? February 9, 2016

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer January 27, 2016

A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer January 6, 2016

Molecular Mechanisms of Bone Metastasis December 31, 2015

Page 6 of 10